IDH1 status and survival benefit from surgical resection of enhancing and nonenhancing tumor in malignant astrocytomas.
Daniel P. Cahill
No relevant relationships to disclose
Jason Beiko
No relevant relationships to disclose
Dima Suki
No relevant relationships to disclose
Sujit S. Prabhu
No relevant relationships to disclose
Jeffrey Weinberg
No relevant relationships to disclose
Frederick F. Lang
No relevant relationships to disclose
Mark R. Gilbert
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Ganesh Rao
No relevant relationships to disclose
Ian E. McCutcheon
No relevant relationships to disclose
Kenneth D. Aldape
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Raymond Sawaya
No relevant relationships to disclose